Your session is about to expire
← Back to Search
Peritoneal Resuscitation for Liver Disease
Study Summary
This trial is assessing the safety of using a dextrose solution to improve blood flow in high-risk liver transplant patients. The goal is to see if this method is as effective and safe as it has been in other surgical patients.
- End Stage Liver Disease
- Acute Kidney Injury
- Obesity
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have an injury to your diaphragm.You have a severe bacterial infection in your abdomen that has been treated with antibiotics shortly before the surgery.Adults who have had a liver transplant and are 18 years old or older.Your kidney function (creatinine) is not working well before surgery and your body mass index (BMI) is high.
- Group 1: Direct Peritoneal Resuscitation (DPR) Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the recruitment process for this experiment still open?
"Affirmative, clinicaltrials.gov provides evidence that this medical trial is still searching for participants; it was initially advertised on February 1st 2022 and recently updated the same day. 15 people need to be recruited from one single site."
What adverse effects could result from Direct Peritoneal Resuscitation?
"Our team assigned Direct Peritoneal Resuscitation a score of 1 as it is currently undergoing Phase 1 testing, meaning there is only limited evidence regarding safety and efficacy."
What is the current capacity of this clinical trial?
"Affirmative. According to information hosted on clinicaltrials.gov, this research is currently attempting to recruit participants as of February 1st 2022 and was last updated that same day. 15 individuals are needed at a single site for the trial."
Share this study with friends
Copy Link
Messenger